Page last updated: 2024-09-03

1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol and 5,8,11,14-eicosatetraynoic acid

1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol has been researched along with 5,8,11,14-eicosatetraynoic acid in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol)
Trials
(1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol)
Recent Studies (post-2010)
(1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol)
Studies
(5,8,11,14-eicosatetraynoic acid)
Trials
(5,8,11,14-eicosatetraynoic acid)
Recent Studies (post-2010) (5,8,11,14-eicosatetraynoic acid)
23010573116

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol (IC50)5,8,11,14-eicosatetraynoic acid (IC50)
Mcl-1Homo sapiens (human)1.78
Myeloid cell leukemia sequence 1 (BCL2-related)Homo sapiens (human)0.4415
envelope glycoproteinHuman immunodeficiency virus 111.9
VifHuman immunodeficiency virus 10.86
TatHuman immunodeficiency virus 12.379
DNA dC->dU-editing enzyme APOBEC-3G isoform 1Homo sapiens (human)0.86
dual specificity protein phosphatase 6Rattus norvegicus (Norway rat)21.683
tyrosine-protein phosphatase non-receptor type 7 isoform 2Homo sapiens (human)17.7
Muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)1.78
Muscarinic acetylcholine receptor M3Rattus norvegicus (Norway rat)1.78
Muscarinic acetylcholine receptor M4Rattus norvegicus (Norway rat)1.78
Muscarinic acetylcholine receptor M5Rattus norvegicus (Norway rat)1.78
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)1.78

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
al-Mehdi, AB; Dodia, C; Fisher, AB; Jain, MK1

Other Studies

1 other study(ies) available for 1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol and 5,8,11,14-eicosatetraynoic acid

ArticleYear
A phospholipase A2 inhibitor decreases generation of thiobarbituric acid reactive substance during lung ischemia-reperfusion.
    Biochimica et biophysica acta, 1993, Mar-17, Volume: 1167, Issue:1

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Glycerophosphates; Ischemia; Lipid Peroxidation; Lung; Male; Organ Size; Perfusion; Phospholipases A; Phospholipases A2; Rats; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances

1993